I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Table_1_Cost-effectiveness analysis of metronomic capecitab..:
Longjiang She
;
Kun Tian
;
Jiaqi Han
...
doi:10.3389/fonc.2022.904372.s004. , 2022
Link:
https://doi.org/10.3389/fonc.2022.904372.s004
RT Journal T1
Table_1_Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma.docx
UL https://suche.suub.uni-bremen.de/peid=base-ftfrontimediafig:oai:figshare.com:article_21086818&Exemplar=1&LAN=DE A1 Longjiang She A1 Kun Tian A1 Jiaqi Han A1 Weihan Zuo A1 Zhu Wang A1 Ning Zhang YR 2022 K1 Cancer K1 Cancer Cell Biology K1 Cancer Diagnosis K1 Cancer Genetics K1 Cancer Therapy (excl. Chemotherapy and Radiation Therapy) K1 Chemotherapy K1 Haematological Tumours K1 Molecular Targets K1 Radiation Therapy K1 Solid Tumours K1 Oncology and Carcinogenesis not elsewhere classified K1 cost-effectiveness K1 metronomic chemotherapy K1 adjuvant chemotherapy K1 capecitabine K1 nasopharyngeal carcinoma JF doi:10.3389/fonc.2022.904372.s004 LK http://dx.doi.org/https://doi.org/10.3389/fonc.2022.904372.s004 DO https://doi.org/10.3389/fonc.2022.904372.s004 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)